ÉTUDE prodige 107-FFCD-COLOSOTO - En cours de lancement
Title
A single-arm phase II study evaluating 5-fluorouracil plus Panitumumab (anti-EGFR) and Sotorasib (KRAS G12C inhibitor) in first-line treatment of patients non-eligible for a doublet/triplet chemotherapy with advanced unresectable KRAS G12C mutated colorectal adenocarcinoma
Coordonateur
TOUGERON D
Co-Coordonateur
Promoteur
FFCD